SIAP
Sterling Investment Advisors (Pennsylvania)’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Sell |
3,697
-15
| -0.4% | -$7.88K | 0.43% | 68 |
|
|
2025
Q1 | $2.35M | Sell |
3,712
-50
| -1% | -$31.7K | 0.57% | 55 |
|
|
2024
Q4 | $2.68M | Buy |
3,762
+715
| +23% | +$509K | 0.65% | 50 |
|
|
2024
Q3 | $3.2M | Sell |
3,047
-280
| -8% | -$294K | 0.81% | 41 |
|
|
2024
Q2 | $3.5M | Sell |
3,327
-25
| -0.7% | -$26.3K | 0.95% | 31 |
|
|
2024
Q1 | $3.23M | Sell |
3,352
-115
| -3% | -$111K | 0.91% | 37 |
|
|
2023
Q4 | $3.05M | Sell |
3,467
-70
| -2% | -$61.5K | 0.95% | 33 |
|
|
2023
Q3 | $2.91M | Hold |
3,537
| – | – | 1.02% | 33 |
|
|
2023
Q2 | $2.54M | Sell |
3,537
-215
| -6% | -$154K | 0.84% | 38 |
|
|
2023
Q1 | $3.08M | Buy |
3,752
+319
| +9% | +$262K | 1.04% | 31 |
|
|
2022
Q4 | $2.48M | Sell |
3,433
-150
| -4% | -$108K | 0.89% | 41 |
|
|
2022
Q3 | $2.47M | Sell |
3,583
-250
| -7% | -$172K | 0.92% | 34 |
|
|
2022
Q2 | $2.27M | Sell |
3,833
-160
| -4% | -$94.6K | 0.78% | 41 |
|
|
2022
Q1 | $2.79M | Sell |
3,993
-180
| -4% | -$126K | 0.79% | 39 |
|
|
2021
Q4 | $2.64M | Sell |
4,173
-36
| -0.9% | -$22.7K | 0.74% | 46 |
|
|
2021
Q3 | $2.55M | Buy |
4,209
+11
| +0.3% | +$6.66K | 0.76% | 41 |
|
|
2021
Q2 | $2.35M | Buy |
4,198
+295
| +8% | +$165K | 0.69% | 45 |
|
|
2021
Q1 | $1.85M | Buy |
3,903
+3,875
| +13,839% | +$1.83M | 0.6% | 58 |
|
|
2020
Q4 | $14K | Sell |
28
-100
| -78% | -$50K | ﹤0.01% | 334 |
|
|
2020
Q3 | $72K | Sell |
128
-900
| -88% | -$506K | 0.03% | 190 |
|
|
2020
Q2 | $641K | Hold |
1,028
| – | – | 0.27% | 84 |
|
|
2020
Q1 | $501K | Buy |
1,028
+1,000
| +3,571% | +$487K | 0.26% | 81 |
|
|
2019
Q4 | $10K | Sell |
28
-300
| -91% | -$107K | ﹤0.01% | 337 |
|
|
2019
Q3 | $91K | Sell |
328
-50
| -13% | -$13.9K | 0.05% | 157 |
|
|
2019
Q2 | $118K | Hold |
378
| – | – | 0.06% | 144 |
|
|
2019
Q1 | $155K | Hold |
378
| – | – | 0.08% | 127 |
|
|
2018
Q4 | $141K | Hold |
378
| – | – | 0.08% | 125 |
|
|
2018
Q3 | $153K | Hold |
378
| – | – | 0.08% | 130 |
|
|
2018
Q2 | $130K | Hold |
378
| – | – | 0.08% | 128 |
|
|
2018
Q1 | $130K | Hold |
378
| – | – | 0.08% | 124 |
|
|
2017
Q4 | $142K | Buy |
378
+100
| +36% | +$37.6K | 0.09% | 122 |
|
|
2017
Q3 | $124K | Hold |
278
| – | – | 0.08% | 124 |
|
|
2017
Q2 | $137K | Buy |
278
+28
| +11% | +$13.8K | 0.09% | 119 |
|
|
2017
Q1 | $97K | Hold |
250
| – | – | 0.07% | 128 |
|
|
2016
Q4 | $92K | Buy |
+250
| New | +$92K | 0.07% | 120 |
|